|
SMCR8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.175000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.844000E-01 |
| Normal-vs-Stage2 |
4.498300E-02 |
| Normal-vs-Stage3 |
2.36509999999024E-05 |
| Normal-vs-Stage4 |
1.73325999999197E-05 |
| Stage1-vs-Stage2 |
6.526100E-02 |
| Stage1-vs-Stage3 |
3.70400000000437E-05 |
| Stage1-vs-Stage4 |
3.62449999999903E-05 |
| Stage2-vs-Stage3 |
2.327000E-01 |
| Stage2-vs-Stage4 |
1.195960E-01 |
| Stage3-vs-Stage4 |
6.184200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.537800E-03 |
| Normal-vs-AfricanAmerican |
8.382500E-02 |
| Normal-vs-Asian |
2.466400E-01 |
| Caucasian-vs-AfricanAmerican |
9.674400E-01 |
| Caucasian-vs-Asian |
2.540200E-02 |
| AfricanAmerican-vs-Asian |
4.380200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.503210E-03 |
| Normal-vs-Female |
1.164960E-01 |
| Male-vs-Female |
1.527010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.594100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.260570E-01 |
| Normal-vs-Age(61-80Yrs) |
2.203900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.128400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.611800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.086400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.485000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.227230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.983800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.641400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.166000E-02 |
| Normal-vs-Grade 2 |
2.928400E-01 |
| Normal-vs-Grade 3 |
4.698200E-03 |
| Normal-vs-Grade 4 |
1.45040000010255E-07 |
| Grade 1-vs-Grade 2 |
3.083900E-02 |
| Grade 1-vs-Grade 3 |
6.357400E-03 |
| Grade 1-vs-Grade 4 |
2.4314999999997E-05 |
| Grade 2-vs-Grade 3 |
5.258000E-02 |
| Grade 2-vs-Grade 4 |
4.54670000005208E-06 |
| Grade 3-vs-Grade 4 |
3.716800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.225600E-01 |
| Normal-vs-ccB subtype |
1.241150E-03 |
| ccA subtype-vs-ccB subtype |
2.377300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.152300E-02 |
| Normal-vs-N1 |
3.998400E-01 |
| N0-vs-N1 |
8.099800E-01 |
|
|
